Mochida Pharmaceutical Co Ltd MFY

Morningstar Rating
€17.40 −0.10 (0.57%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MFY is trading at a LOCK|D#@#$ premium.
Price
€17.40
Fair Value
LOCK|.xDcW<JF
Uncertainty
LOCK|$d
1-Star Price
LOCK|.N@l@yb
5-Star Price
LOCK|.T?#DD&
Economic Moat
LOCK|!r
Capital Allocation
—

Trading Information

Previous Close Price
€17.50
Day Range
€17.40–17.40
52-Week Range
€16.20–—
Bid/Ask
€0.00 / €0.00
Shares Outstanding
35.12M
Market Cap
¥611.15M
Volume/Avg
— / —

Key Statistics

Price/Earnings (Normalized)
12.16
Price/Sales
0.92
Dividend Yield (Trailing)
2.60%
Dividend Yield (Forward)
2.74%
Dividend Payment Schedule
Jun, Dec
Total Yield
2.61%

Company Profile

Mochida Pharmaceutical Co Ltd is a drug manufacturing company engaged in manufacturing, procurement, and sale of pharmaceutical and healthcare-related product. The company operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of creative new drugs. The healthcare segment entrusts the manufacturing of healthcare products.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
1,966

Valuation

Metric
MFY
Price/Earnings (Normalized)
12.16
Price/Book Value
0.82
Price/Sales
0.92
Price/Cash Flow
10.47
Price/Earnings
MFY

Financial Strength

Metric
MFY
Quick Ratio
2.44
Current Ratio
3.94
Interest Coverage
115.30
Quick Ratio
MFY

Profitability

Metric
MFY
Return on Assets (Normalized)
7.21%
Return on Equity (Normalized)
9.20%
Return on Invested Capital (Normalized)
8.58%
Return on Assets
MFY

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|H<^MGQsYLOCK|@R%T$67B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|?kdRC!kmLOCK|<rRQb$49B
Haleon PLC ADR
HLN
LOCK|<@NTMCdLOCK|K&$41B
Zoetis Inc Class A
ZTS
LOCK|F>?dZ$>pLOCK|qxw$31B
Viatris Inc
VTRS
LOCK|MT$>xFLOCK|?VS$20B
Elanco Animal Health Inc
ELAN
LOCK|YH@LOCK|k#$11B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|rb?f&XLOCK|zN$11B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|wzK@lD#LOCK|GM$6B
Prestige Consumer Healthcare Inc
PBH
LOCK|Dxx<Wl^LOCK|lFSlr$2B
Perrigo Co PLC
PRGO
LOCK|zl%fs%LOCK|crd$2B

Sponsor Center